H. F. Lynch

发表

Bystander risk, social value, and ethics of human research

Seema K. Shah, A. Lyerly, H. Lynch, 2018, Science.

"We measure what we can measure": Struggles in defining and evaluating institutional review board quality.

H. Lynch, J. Clapp, Whitney Eriksen, 2021, Social science & medicine.

Of Parachutes and Participant Protection: Moving Beyond Quality to Advance Effective Research Ethics Oversight

M. Meyer, H. Lynch, H. Taylor, 2018, Journal of empirical research on human research ethics : JERHRE.

Implementing Regulatory Broad Consent Under the Revised Common Rule: Clarifying Key Points and the Need for Evidence

Mark Barnes, H. Lynch, L. Wolf, 2019, Journal of Law, Medicine & Ethics.

Incorporating ethical principles into clinical research protocols: a tool for protocol writers and ethics committees

Jacquelyn Murphy, Marc Wilenzick, B. Bierer, 2016, Journal of Medical Ethics.

Using Social Media as a Research Recruitment Tool: Ethical Issues and Recommendations

Holly Fernandez Lynch, I Glenn Cohen, Robin Pierce, 2017, The American journal of bioethics : AJOB.

Patient-Engaged Research: Choosing the "Right" Patients to Avoid Pitfalls.

H. Lynch, E. Largent, Matthew S. McCoy, 2018, The Hastings Center report.

Human Research Subjects as Human Research Workers

H. Lynch, H. F. Lynch, 2013, Yale journal of health policy, law, and ethics.

FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies

I. Glenn Cohen, Holly Fernandez Lynch, I. Cohen, 2015 .

Life on an Emotional Roller Coaster: NFL Players and Their Family Members’ Perspectives on Player Mental Health

I. Cohen, H. Lynch, S. McGraw, 2018, Journal of Clinical Sport Psychology.

Ethics of controlled human infection to address COVID-19

Seema K. Shah, M. Selgelid, H. Lynch, 2020, Science.

Helpful Lessons and Cautionary Tales: How Should COVID-19 Drug Development and Access Inform Approaches to Non-Pandemic Diseases?

A. Caplan, H. Lynch, Alison Bateman-House, 2021, The American journal of bioethics : AJOB.

INTRODUCTION Health Law and Anti-Racism: Reckoning and Response

M. Goodwin, H. F. Lynch, 2022, Journal of Law, Medicine & Ethics.

NFL or 'Not For Long'? Transitioning Out of the NFL

H. Lynch, S. McGraw, Alixandra A. Nozzolillo, 2019 .

The Legality of Biometric Screening of Professional Athletes

I. Cohen, Chris Deubert, Jessica Roberts, 2017, The American journal of bioethics : AJOB.

Scholarly Commons at Boston University School of Law Scholarly Commons at Boston University School of Law

I. G. Cohen, H. F. Lynch, John Rex, 2022 .

Journeying to Ixtlan: Ethics of Psychedelic Medicine and Research for Alzheimer’s Disease and Related Dementias

J. Karlawish, H. Lynch, E. Largent, 2022, AJOB neuroscience.

Addressing Financial Barriers to Enrollment in Clinical Trials.

H. Lynch, E. Largent, H. F. Lynch, 2018, JAMA oncology.

A Framework for Ethical Payment to Research Participants

I. Cohen, B. Bierer, H. Lynch, 2018, The New England journal of medicine.

Paying Research Participants: The Outsized Influence of "Undue Influence".

H. Lynch, E. Largent, Emily A. Largent, 2017, IRB.

Federal Right-to-Try Legislation - Threatening the FDA's Public Health Mission.

S. Joffe, H. F. Lynch, 2018, The New England journal of medicine.

Steps toward a System of IRB Precedent: Piloting Approaches to Summarizing IRB Decisions for Future Use.

B. Bierer, H. Lynch, C. Coleman, 2021, Ethics & Human Research.

Inclusive, engaged, and accountable institutional review boards.

Ann R. Johnson, E. Anderson, H. F. Lynch, 2023, Accountability in research.

Opening Closed Doors: Promoting IRB Transparency

H. Lynch, H. F. Lynch, 2018, Journal of Law, Medicine & Ethics.

When religious freedom clashes with access to care.

I. Cohen, H. Lynch, G. Curfman, 2014, The New England journal of medicine.

When clinical trials compete: prioritising study recruitment

I. Cohen, B. Bierer, H. Lynch, 2017, Journal of Medical Ethics.

Academic Advocacy: Opportunities to Influence Health and Science Policy Under U.S. Lobbying Law.

Suzanne M. Rivera, H. Lynch, Alison Bateman-House, 2019, Academic medicine : journal of the Association of American Medical Colleges.

Aspiring to Reasonableness in Accelerated Approval: Anticipating and Avoiding the Next Aducanumab

H. Lynch, E. Largent, Jason Karlawish, 2022, Drugs & Aging.

Confronting Biospecimen Exceptionalism in Proposed Revisions to the Common Rule.

I. Cohen, B. Bierer, H. F. Lynch, 2016, The Hastings Center report.

Nudging Health: Health Law and Behavioral Economics

C. Sunstein, I. Cohen, C. Robertson, 2016 .